ストックスクリーナーアプリを入手
112.10
2.83%
-3.27
アフターアワーズ：
114.32
2.22
+1.98%
Glaukos Corporation (GKOS) 最新ニュース
Glaucoma Surgery Device Market Is Going to Boom | Glaukos Corporation • Santen Pharmaceutical • Carl Zeiss AG - openPR.com
Glaukos Corporation $GKOS Shares Purchased by AustralianSuper Pty Ltd - MarketBeat
Should You Buy Glaukos Corp (GKOS) Today? Analysis, Price Targets, and 2026 Outlook. - Intellectia AI
Glaukos’ 2025 Loss, Impairment and ESOP Shelf Might Change The Case For Investing In GKOS - simplywall.st
Glaukos Corporation (GKOS) Stock Analysis: Potential 11.95% Upside Amid Robust Revenue Growth - DirectorsTalk Interviews
William Blair Investment Management LLC Has $89.20 Million Holdings in Glaukos Corporation $GKOS - MarketBeat
Glaukos Highlights Interventional Ophthalmology Strategy in Investor Update - TipRanks
Glaukos : Investor Presentation March 2026 - marketscreener.com
Glaukos unveils March 2026 investor presentation highlighting iDose TR approval, Epioxa launch and 2026 $610M sales guide - TradingView
Glaukos (GKOS) furnishes March 2026 Investor Presentation for stakeholders - Stock Titan
DNB Asset Management AS Purchases 16,267 Shares of Glaukos Corporation $GKOS - MarketBeat
GKOS SEC FilingsGlaukos Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Glaukos Expands Eye Care Pipeline With New GLK-321 Trial in Demodex Blepharitis - TipRanks
Primecap Management Co. CA Grows Stake in Glaukos Corporation $GKOS - MarketBeat
Fox Run Management L.L.C. Purchases Shares of 12,308 Glaukos Corporation $GKOS - MarketBeat
Glaukos : Statement of Changes in Beneficial Ownership (Form 4) - marketscreener.com
Glaukos (NYSE: GKOS) CEO has 4,059 shares withheld to cover taxes - Stock Titan
Glaukos (NYSE: GKOS) CDO reports 396-share tax-withholding disposition - Stock Titan
GLAUKOS (GKOS) COO’s RSU vesting triggers 1,057-share tax withholding - Stock Titan
Glaukos Corporation $GKOS Shares Acquired by Westfield Capital Management Co. LP - MarketBeat
21,717 Shares in Glaukos Corporation $GKOS Acquired by Zhang Financial LLC - MarketBeat
Glaukos Corporation $GKOS Stock Holdings Decreased by Vanguard Group Inc. - MarketBeat
JPMorgan Chase & Co. Acquires 27,646 Shares of Glaukos Corporation $GKOS - MarketBeat
Should Glaukos’ (GKOS) Big 2026 Sales Target and ESOP Shelf Filing Require Action From Investors? - Yahoo Finance
(GKOS) Risk Channels and Responsive Allocation - Stock Traders Daily
GKOS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Glaukos Corp. Experiences Revision in Its Stock Evaluation Amid Financial Performance Trends - Markets Mojo
AI Adoption Raises Operational, Regulatory, and Reputational Risks for Glaukos Corp. - TipRanks
Insider Selling: Glaukos (NYSE:GKOS) Director Sells 15,000 Shares of Stock - MarketBeat
Glaukos (GKOS) director exercises 15K options and sells 15K shares - Stock Titan
Strong Results with 38.1% Revenue Growth Lifted Glaukos (GKOS) in Q4 - Bitget
Granite Investment Partners LLC Sells 55,233 Shares of Glaukos Corporation $GKOS - MarketBeat
GLAUKOS Corp SEC 10-K Report - TradingView
Glaukos (GKOS) Is Up 9.9% After Issuing Robust 2026 Sales Outlook Amid Net Losses – What's Changed - simplywall.st
Moving Averages: Is Glaukos Corporation trading at a discountMarket Sentiment Summary & Weekly Return Optimization Plans - baoquankhu1.vn
Glaukos Corporation (NYSE:GKOS) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Can Glaukos Corporation stock hit record highs again2025 Momentum Check & Free Long-Term Investment Growth Plans - mfd.ru
Sentiment Review: Is Glaukos Corporation affected by consumer sentiment2025 Trading Volume Trends & AI Based Trade Execution Alerts - baoquankhu1.vn
Glaukos (NYSE:GKOS) Cut to "Hold" at Wall Street Zen - MarketBeat
Glaukos Corporation Q4 2025 Earnings Call Summary - Yahoo Finance
Glaukos Stock Jumps 13% After Q4 Beat: Here’s What Its 2026 Guidance Signals - TIKR.com
Glaukos stock steadies premarket after a 13% surge — what GKOS investors watch next - Bez Kabli
Needham raises Glaukos stock price target on iDose, Epioxa growth By Investing.com - Investing.com India
[144] GLAUKOS Corp SEC Filing - Stock Titan
Needham raises Glaukos stock price target on iDose, Epioxa growth - Investing.com Nigeria
Why Analysts See Glaukos (GKOS) Story Shifting As iDose Repeat Dosing Takes Center Stage - Yahoo Finance
Glaukos Corp. Earnings Call Signals High-Growth Phase - TipRanks
GKOS: Needham Raises Price Target for Glaukos to $127 | GKOS Sto - GuruFocus
Glaukos (NYSE:GKOS) Jumps After Qtrly Revenue Beat - Kalkine Media
Glaukos (NYSE:GKOS) Trading 8.4% HigherWhat's Next? - MarketBeat
Stifel reiterates Glaukos stock rating on product momentum By Investing.com - Investing.com Nigeria
Glaukos Stock Shoots Up After iDose TR Re-administration Approval - StocksToTrade
Stifel reiterates Glaukos stock rating on product momentum - Investing.com
Glaukos outlines 2026 sales target of $600M–$620M as iDose TR and Epioxa drive growth momentum - MSN
Glaukos Misses Q4 Earnings Estimates, Raises 2026 Revenue Outlook - Nasdaq
Glaukos (GKOS): Wells Fargo Raises Price Target to $135 | GKOS S - GuruFocus
These Analysts Boost Their Forecasts On Glaukos Following Q4 Results - Benzinga
2.40%
大文字化:
|
ボリューム (24 時間):